Skip to main content
BIOVENTIX PLC logo

BIOVENTIX PLC — Investor Relations & Filings

Ticker · BVXP ISIN · GB00B4QVDF07 LEI · 213800225MHX7LZQY108 IL Manufacturing
Open in API
Filings indexed 211 across all filing types
Latest filing 2016-03-21 Interim / Quarterly Rep…
Country GB United Kingdom
Listing IL BVXP

About BIOVENTIX PLC

https://www.bioventix.com/

Bioventix PLC is a biotechnology company that specializes in the development, creation, and commercial supply of high-affinity sheep monoclonal antibodies (SMAs). These antibodies are utilized by global diagnostic companies as critical components in clinical diagnostic platforms, particularly for blood testing immunoassays. The company's portfolio supports a variety of applications, including diagnostics for cardiovascular conditions (troponin), oncology, and neurodegenerative diseases such as Alzheimer's. In addition to its core antibody products, Bioventix also provides ELISA kits for monitoring exposure to industrial pollutants and offers contract services for the development of new SMAs for healthcare organizations.

Recent filings

Filing Released Lang Actions
BIOVENTIX PLC - Half-yearly Report
Interim / Quarterly Report Classification · 100% confidence The document is titled 'BIOVENTIX PLC - Half-yearly Report' and contains comprehensive financial statements, including a Profit and Loss Account, Balance Sheet, and Cash Flow Statement for the six-month period ended 31 December 2015. It also includes management commentary and notes to the financial information. As it provides substantive financial data for an interim period, it is classified as an Interim/Quarterly Report. H1 2015
2016-03-21 English
BIOVENTIX PLC - Investment in CardiNor
Regulatory Filings Classification · 95% confidence The document is a press release announcing a strategic investment and collaboration between Bioventix plc and CardiNor AS regarding the development of a cardiovascular diagnostic test. It details the terms (10% shareholding for Bioventix) and the scientific rationale. This type of announcement, detailing corporate transactions, partnerships, or significant business developments that are not standard periodic financial reports (like 10-K or IR), typically falls under general regulatory announcements or corporate actions. Since it is not a formal M&A filing (TAR), a financing update (CAP), or a management change (MANG), and it is a news release format, it best fits the general Regulatory Filings (RNS) category, which serves as a broad category for non-standard corporate news releases.
2016-01-14 English
BIOVENTIX PLC - Result of AGM
AGM Information Classification · 100% confidence The document explicitly states in the title and body: "# BIOVENTIX PLC - Result of AGM" and "Bioventix plc announces that at its Annual General Meeting held yesterday afternoon, all resolutions put to shareholders were duly passed." This content directly relates to the outcomes of the Annual General Meeting (AGM). According to the definitions, materials shared during the AGM fall under 'AGM Information' (Code: AGM-R). The document is short and reports the result, fitting the AGM-R category better than a general Regulatory Filing (RNS).
2015-12-03 English
BIOVENTIX PLC - Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is titled 'TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES' and details an acquisition or disposal of voting rights by 'Henderson Global Investors' in 'Bioventix plc'. This type of filing, which reports changes in significant share ownership thresholds (crossing below 14% & 13%), directly corresponds to the definition of a Major Shareholding Notification. The code for this is MRQ.
2015-11-19 English
BIOVENTIX PLC - Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is titled 'TR-1: NOTIFICATION OF MAJOR INTEREST IN Shares' and details an acquisition or disposal of voting rights by 'The Diverse Income Trust Plc' in 'Bioventix Plc'. It explicitly mentions crossing a threshold ('Below 6%') and provides detailed tables showing the number of shares and resulting percentage of voting rights (5.99%). This structure is characteristic of a mandatory regulatory filing notifying a change in significant shareholding, which corresponds to the Major Shareholding Notification category.
2015-11-19 English
BIOVENTIX PLC - Holding(s) in Company
Major Shareholding Notification Classification · 98% confidence The document is titled 'TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES' and details changes in voting rights and shareholdings for BIOVENTIX PLC by MITON GROUP PLC. This structure, including sections for 'Reason for the notification', 'Date of the transaction', and 'Notified details' regarding voting rights, is characteristic of regulatory filings concerning significant ownership changes. Specifically, this aligns with notifications required when a shareholder crosses a major interest threshold (like 5%, 10%, 15%, etc.). Among the provided codes, 'Major Shareholding Notification' (MRQ) is the most appropriate fit for reporting changes in significant share ownership levels crossing thresholds.
2015-11-19 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.